ESC 365 - Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation

ESC Premium Access

Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation

Session: Young Investigator Awards Session in Thrombosis

Topic: Biomarkers

Speaker: Ms L. Willems (Nijmegen, NL)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Ms Loes Willems

Radboud University Medical Center, Nijmegen (Netherlands (The))

0 follower

3 more presentations in this session

JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression

Speaker: Doctor L. Liberale (Genova, IT)

In vivo coronary artery thrombus imaging with 18F-GP1 PET-CT

Speaker: Doctor E. Tzolos (Edinburgh, GB)

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

Speaker: Mr F. Alenazy (Birmingham, GB)

Access the full session

Young Investigator Awards Session in Thrombosis

Speakers: Ms L. Willems, Doctor L. Liberale, Doctor E. Tzolos, Mr F. Alenazy

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources